Acyl-coA Binding Protein neutralization improves cancer immunosurveillance
Ontology highlight
ABSTRACT: The plasma concentrations of acyl coenzyme A binding protein (ACBP, also known as diazepam-binding inhibitor, DBI, or ‘endozepine’) increase with age and obesity, two parameters that are also the most important risk factors for cancer. In mice bearing MCA205 fibrosarcoma, antibody mediated ACBP/DBI neutralization enhanced the anticancer T-cell response in the context of chemoimmunotherapy. T-cells infiltrating MCA205 tumors were sorted and submitting to single-cell TCR sequencing and single-cell RNA sequencing (scRNAseq) to identify the mechanisms driving this improvement.
ORGANISM(S): Mus musculus
PROVIDER: GSE242119 | GEO | 2024/09/11
REPOSITORIES: GEO
ACCESS DATA